All the recipients of e-B cells, whether CD9+, CD9−, or unseparated total e-B cells, were protected from the BDC2.5 CD4+ T cell-induced diabetes (Figure 8A and summarized in Figure 8B). This evidence concerns the gene CD4 and diabetes mellitus.